Amatuer17
1 year ago
https://seekingalpha.com/article/4594258-verona-pharma-ensifentrine-vs-dupixent-ensifentrine-is-a-breath-of-fresh-air
Firstly, in the Phase 3 ENHANCE-1 and ENHANCE-2 trials, ensifentrine reported a 36% and 42% pbo-adjusted reduction in COPD exacerbation at week 24, respectively. In contrast, dupixent demonstrated a 30% pbo-adjusted reduction in COPD exacerbation at week 52 in the BOREAS trial.
Verona Pharma is expected to submit an NDA by 1H 2023, PDUFA by 1H 2024, and launch in the US by 2H 2024.
crudeoil24
2 years ago
Verona Pharma Announces Proposed Underwritten Public Offering Of 10M ADSs
4:42 pm ET August 9, 2022 (Benzinga) Print
Verona Pharma plc (NASDAQ:VRNA) ("Verona Pharma" or the "Company"), a clinical-stage biopharmaceutical company focused on respiratory diseases, today announced a proposed underwritten public offering of 10 million American Depositary Shares ("ADSs"), each representing eight ordinary shares of Verona Pharma, nominal value £0.05 per share (the "Offering"). All ADSs in the Offering will be offered by Verona Pharma. The Offering is subject to market and other conditions, and there can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the offering. In addition, Verona Pharma intends to grant the underwriters of the Offering a 30-day option to purchase up to an additional 1.5 million ADSs at the public offering price, less the underwriting discount and commission.
dinogreeves
4 years ago
This is not me saying, this is analyst saying it. Big difference. I am laughing because you tend to follow me around, but that is ok, the more you follow me around, I see that you didn't follow me on CP*AH, some picks I make bank and some picks go against me, no one is perfect, no one, not even the analyst in their projects. But the bottom line still remains, COPD is a huge market, when the dust settles it will move North when you least expect it, heck I predicted 80 dollars on CR*TX and hit a few dollars just under that, I predicted CP*AH will hit between 2-3 dollars and possibly $5 and it went well over 5 dollars yesterday, heck I predicted LL*EX could be bought out for a premium and they just had an offer on the table for 25 cents well under my prediction, but heck at least I said they could get bought out, the shareholder have no choice but to sell if for that price. No one is perfect in the world trading, but at least I am 70% accurate with my predictions, to me, that is enough to make a good solid returns on annual basis. For now, you can go to trading OTC.